Boundless Bio is a clinical stage, next-generation precision oncology company advancing a robust pipeline of the next wave of cancer medicines, ecDNA-directed therapies (ecDTx) for patients with oncogene amplified cancers
Boundless Bio is a clinical stage, next-generation precision oncology company advancing a robust pipeline of the next wave of cancer medicines, ecDNA-directed therapies (ecDTx) for patients with oncogene amplified cancers.
Boundless Bio is a clinical stage, next-generation precision oncology company advancing a robust pipeline of the next wave of cancer medicines, ecDNA-directed therapies (ecDTx) for patients with oncogene amplified cancers
Boundless Bio is a clinical stage, next-generation precision oncology company advancing a robust pipeline of the next wave of cancer medicines, ecDNA-directed therapies (ecDTx) for patients with oncogene amplified cancers.